Seer, Inc. (SEER)
SEER Stock Price Chart
Explore Seer, Inc. interactive price chart. Choose custom timeframes to analyze SEER price movements and trends.
SEER Company Profile
Discover essential business fundamentals and corporate details for Seer, Inc. (SEER) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Dec 2020
Employees
134.00
Website
https://seer.bioCEO
Omid C. Farokhzad
Description
Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software. This comprehensive solution empowers researchers to conduct advanced proteomic studies across various applications, including therapeutic and diagnostic investigations, as well as clinical trials. The company markets its products exclusively for research applications, serving academic institutions, diverse life sciences and research laboratories, and biopharmaceutical and biotechnology enterprises. Notably, these offerings are intended for non-diagnostic and non-clinical purposes. Seer has established collaborative agreements with entities such as Discovery Life Sciences, LLC, and the Salk Institute for Biological Studies. Originally incorporated in 2017 as Seer Biosciences, Inc., the company adopted its current name, Seer, Inc., in July 2018. Its headquarters are situated in Redwood City, California.
SEER Financial Timeline
Browse a chronological timeline of Seer, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is -$0.27, while revenue estimate is $3.55m.
Earnings released on 13 May 2026
EPS came in at -$0.30 falling short of the estimated -$0.30 by -1.69%, while revenue for the quarter reached $2.79m , missing expectations by -22.42%.
Earnings released on 26 Feb 2026
EPS came in at -$0.29 surpassing the estimated -$0.32 by +9.38%, while revenue for the quarter reached $4.20m , missing expectations by -8.67%.
Earnings released on 6 Nov 2025
EPS came in at -$0.32 matching the estimated -$0.32, while revenue for the quarter reached $4.12m , missing expectations by -10.41%.
Earnings released on 6 Aug 2025
EPS came in at -$0.33 surpassing the estimated -$0.39 by +15.38%, while revenue for the quarter reached $4.05m , beating expectations by +8.03%.
Earnings released on 13 May 2025
EPS came in at -$0.34 surpassing the estimated -$0.37 by +8.11%, while revenue for the quarter reached $4.21m , beating expectations by +3.83%.
Earnings released on 27 Feb 2025
EPS came in at -$0.34 falling short of the estimated -$0.31 by -9.68%, while revenue for the quarter reached $3.95m , missing expectations by -0.03%.
Earnings released on 6 Nov 2024
EPS came in at -$0.34 falling short of the estimated -$0.29 by -17.24%, while revenue for the quarter reached $3.94m , missing expectations by -0.20%.
Earnings released on 8 Aug 2024
EPS came in at -$0.35 surpassing the estimated -$0.36 by +2.78%, while revenue for the quarter reached $3.07m , missing expectations by -4.00%.
Earnings released on 8 May 2024
EPS came in at -$0.32 falling short of the estimated -$0.31 by -3.23%, while revenue for the quarter reached $3.07m , missing expectations by -19.32%.
Earnings released on 29 Feb 2024
EPS came in at -$0.28 surpassing the estimated -$0.35 by +20.00%, while revenue for the quarter reached $4.18m , beating expectations by +3.21%.
Earnings released on 7 Nov 2023
EPS came in at -$0.33 surpassing the estimated -$0.38 by +13.16%, while revenue for the quarter reached $3.81m , missing expectations by -5.83%.
Earnings released on 8 Aug 2023
EPS came in at -$0.37 surpassing the estimated -$0.38 by +2.63%, while revenue for the quarter reached $3.47m , missing expectations by -31.56%.
Earnings released on 9 May 2023
EPS came in at -$0.38 falling short of the estimated -$0.37 by -2.70%, while revenue for the quarter reached $3.72m , missing expectations by -5.15%.
Earnings released on 2 Mar 2023
EPS came in at -$0.36 surpassing the estimated -$0.42 by +14.29%, while revenue for the quarter reached $3.86m , missing expectations by -8.21%.
Earnings released on 8 Nov 2022
EPS came in at -$0.38 matching the estimated -$0.38, while revenue for the quarter reached $3.96m , beating expectations by +12.68%.
Earnings released on 9 Aug 2022
EPS came in at -$0.37 surpassing the estimated -$0.39 by +5.13%, while revenue for the quarter reached $3.57m , beating expectations by +9.48%.
Earnings released on 4 May 2022
EPS came in at -$0.38 surpassing the estimated -$0.41 by +7.32%, while revenue for the quarter reached $3.30m , beating expectations by +20.83%.
Earnings released on 28 Feb 2022
EPS came in at -$0.32 surpassing the estimated -$0.34 by +5.88%, while revenue for the quarter reached $3.03m , beating expectations by +35.67%.
Earnings released on 9 Nov 2021
EPS came in at -$0.30 falling short of the estimated -$0.29 by -3.45%, while revenue for the quarter reached $2.15m , beating expectations by +74.39%.
Earnings released on 12 Aug 2021
EPS came in at -$0.27 surpassing the estimated -$0.28 by +3.57%, while revenue for the quarter reached $1.22m , missing expectations by -8.77%.
SEER Stock Performance
Access detailed SEER performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
